Cerebral small vessel disease (SVD) and neuropsychiatric symptoms (NPS) independently increase the risk of cognitive decline. While their co-existence has been reported in the preclinical stage of dementia, longitudinal data establishing the prognosis of their associations, especially in an Asian context remains limited.
Objective:
This study investigated the role of SVD and NPS progressions on cognitive outcomes over 2 years in a dementia-free elderly cohort.
Methods:
170 dementia-free elderly with baseline and 2-year neuropsychological assessments and MRI scans were included in this study. White matter hyperintensities (WMH), lacunes, and microbleeds (CMBs) were graded as markers of SVD. The Neuropsychiatric Inventory (NPI) was used to measure NPS. Generalized estimating equations modelling evaluated the relationship between NPI change and SVD progression. Logistic regression evaluated the risk of incident cognitive decline with both SVD and NPS. All models were adjusted for demographics, baseline cerebrovascular diease, and medial temporal lobe atrophy.
Results:
Higher NPI scores were associated with higher SVD burden at baseline. Subjects with WMH progression had greater increase in total NPI (β[SE] = 0.46[0.19], p = 0.016), driven by hyperactivity subsyndrome (β[SE] = 0.88[0.34], p = 0.007). Subjects with incident CMBs had greater increase in psychosis subsyndrome (β[SE] = 0.89[0.30], p < 0.001). Subjects with progressions in both SVD and NPS were more likely to develop cognitive decline over 2 years (OR[95% CI] = 4.17[1.06–16.40], p < 0.05).
Conclusion:
Our findings support worsening of NPS as a clinical indicator of SVD progression and are associated with cognitive decline over 2 years. Early detection of NPS and targeted interventions on SVD burden may improve NPS outcomes.
PantoniLMD (2010) Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol9, 689–701.
2.
WardlawJM, SmithC, DichgansM (2013) Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging. Lancet Neurol12, 483.
3.
CatindigJA, VenketasubramanianN, IkramMK, ChenC (2012) Epidemiology of dementia in Asia: Insights on prevalence, trends and novel risk factors. J Neurol Sci321, 11.
4.
VenketasubramanianN, SahadevanS, KuaEH, ChenCP, NgTP (2010) Interethnic differences in dementia epidemiology: Global and Asia-Pacific perspectives. Dement Geriatr Cogn Disord30, 492–498.
5.
BalestreriL, GrossbergA, GrossbergGT (2000) Behavioral and psychological symptoms of dementia as a risk factor for nursing home placement. Int Psychogeriatr12, 59–62.
6.
KarttunenK, KarppiP, HiltunenA, VanhanenM, VälimäkiT, MartikainenJ, ValtonenH, SiveniusJ, SoininenH, HartikainenS, SuhonenJ, PirttiläT, ALSOVA study group (2011) Neuropsychiatric symptoms and Quality of Life in patients with very mild and mild Alzheimer’s disease. Int J Geriatr Psychiatry26, 473–482.
7.
OkuraT, LangaKM (2011) Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: The Aging, Demographics, and Memory Study (ADAMS). Alzheimer Dis Assoc Disord25, 116–121.
8.
XuX, AngSL, HilalS, ChanQL, WongTY, VenketasubramanianN, IkramMK, ChenCL (2015) Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly. Int Psychogeriatr27, 1839–1847.
9.
BeaudreauSA, Kaci FairchildJ, SpiraAP, LazzeroniLC, O’HaraR (2013) Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: The Aging, Demographics, and Memory Study (ADAMS). Int J Geriatr Psychiatry28, 672–680.
10.
IsmailZ, SmithEE, GedaY, SultzerD, BrodatyH, SmithG, Agüera-OrtizL, SweetR, MillerD, LyketsosCG (2016) Neuropsychiatric Symptoms Professional Interest Area ISTAART Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement12, 195–202.
11.
OgawaY, HashimotoM, YatabeY, KanedaK, HondaK, YuukiS, HiraiT, IkedaM (2013) Association of cerebral small vessel disease with delusions in patients with Alzheimer’s disease: Small vessel disease and delusions in Alzheimer’s disease. Int J Geriatr Psychiatry28, 18–25.
12.
WuRH, LiQ, TanY, LiuXY, HuangJ (2014) Depression in silent lacunar infarction: A cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors. Neurol Sci35, 1553–1559.
13.
XuX, ChanQL, HilalS, GohWK, IkramMK, WongTY, ChengCY, ChenCL, VenketasubramanianN (2017) Cerebral microbleeds and neuropsychiatric symptoms in an elderly Asian cohort. J Neurol Neurosurg Psychiatry88, 7–11.
14.
NarasimhaluK, AngS, De SilvaDA, WongMC, ChangHM, ChiaKS, AuchusAP, ChenCP (2011) The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke42, 883–888.
15.
XuX, HilalS, CollinsonSL, ChongEJY, IkramMK, VenketasubramanianN, ChenCL-H (2015) Association of magnetic resonance imaging markers of cerebrovascular disease burden and cognition. Stroke46, 2808–2814.
16.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
17.
CummingsJL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology48, S10.
18.
AaltenP, FransRJV, BozikiM, BrugnoloA, BullockR, ByrneEJ, CamusV, CaputoM, CollinsD, Peter Paul DeD, ElinaK, FrisoniG, HolmesC, HurtC, MarriottA, MecocciP, NobiliF, OussetPJ, ReynishE, SalmonE, TsolakiM, VellasB, RobertPH (2007) Consistency of neuropsychiatric syndromes across dementias: Results from the European Alzheimer Disease Consortium: Part II. Dement Geriatr Cogn Disord25, 1.
19.
AaltenP, VerheyFRJ, BozikiM, BullockR, ByrneEJ, CamusV, CaputoM, CollinsD, De DeynPP, ElinaK, FrisoniG, GirtlerN, HolmesC, HurtC, MarriottA, MecocciP, NobiliF, OussetPJ, ReynishE, SalmonE, TsolakiM, VellasB, RobertPH (2007) Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: Part I. Dement Geriatr Cogn Disord24, 457.
20.
WardlawJM, SmithEE, BiesselsGJ, CordonnierC, FazekasF, FrayneR, LindleyRI, O’BrienJT, BarkhofF, BenaventeOR, BlackSE, BrayneC, BretelerM, ChabriatH, DecarliC, de LeeuwFE, DoubalF, DueringM, FoxNC, GreenbergS, HachinskiV, KilimannI, MokV, OostenbruggeR, PantoniL, SpeckO, StephanBC, TeipelS, ViswanathanA, WerringD, ChenC, SmithC, van BuchemM, NorrvingB, GorelickPB, DichgansM (2013) Standards for ReportIng Vascular changes on nEuroimaging (STRIVE, v1) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol12, 822–838.
21.
BenjaminP, TrippierS, LawrenceAJ, LambertC, ZeestratenE, WilliamsOA, PatelB, MorrisRG, BarrickTR, MacKinnonAD, MarkusHS (2018) Lacunar infarcts, but not perivascular spaces, are predictors of cognitive decline in cerebral small-vessel disease. Stroke49, 586–593.
22.
GregoireSM, ChaudharyUJ, BrownMM, YousryTA, KallisC, JagerHR, WerringDJ (2009) The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. Neurology73, 1759–1766.
23.
Martinez-RamirezS, GreenbergSM, ViswanathanA (2014) Cerebral microbleeds: Overview and implications in cognitive impairment. Alzheimers Res Ther6, 33.
24.
WerringDJ (2011), Cerebral microbleeds: Pathophysiology to clinical practice.
Cambridge University Press, Cambridge, UK.
25.
PantoniL, BasileAM, PracucciG, AsplundK, BogousslavskyJ, ChabriatH, ErkinjunttiT, FazekasF, FerroJM, HennericiM, O’BrienJ, ScheltensP, VisserMC, WahlundLO, WaldemarG, WallinA, InzitariD (2005) Impact of age-related cerebral white matter changes on the transition to disability – the LADIS study: Rationale, design and methodology. Neuroepidemiology24, 51–62.
26.
HilalS, MokV, YounYC, WongA, IkramMK, ChenCL-H (2017) Prevalence, risk factors and consequences of cerebral small vessel diseases: Data from three Asian countries. J Neurol Neurosurg Psychiatry88, 669.
27.
GouwAA, van der FlierWM, FazekasF, van StraatenECW, PantoniL, PoggesiA, InzitariD, ErkinjunttiT, WahlundLO, WaldemarG, SchmidtR, ScheltensP, BarkhofF, LADIS Study Group (2008) Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability Study. Stroke39, 1414–1420.
28.
GyanwaliB, ShaikMA, TanBY, VenketasubramanianN, ChenC, HilalS (2019) Risk factors for and clinical relevance of incident and progression of cerebral small vessel disease markers in an Asian Memory Clinic Population. J Alzheimers Dis67, 1209–1219.
ScheltensP, LaunerLJ, BarkhofF, WeinsteinHC, van GoolWA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability. J Neurol242, 557–560.
31.
ScheltensP, PolvdLA (2012) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry83, 1038.
32.
DirekN, PerezHS, AkoudadS, VerhaarenBFJ, NiessenWJ, HofmanA, VernooijMW, IkramMA, TiemeierH (2016) Markers of cerebral small vessel disease and severity of depression in the general population. Psychiatry Res Neuroimaging253, 1–6.
33.
KimHJ, KangSJ, KimC, KimGH, JeonS, LeeJM, OhSJ, KimJS, ChoeYS, LeeKH, NohY, ChoH, YoonCW, ChinJ, CummingsJL, LeeJH, NaDL, SeoSW (2013) The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: A study among patients with subcortical vascular cognitive impairments. Neurobiol Aging34, 1913–1920.
34.
KrishnanMS, O’BrienJT, FirbankMJ, PantoniL, CarlucciG, ErkinjunttiT, WallinA, WahlundLO, ScheltensP, van StraatenECW, InzitariD, LADIS Group (2006) Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry21, 983–989.
35.
BerlowYA, WellsWM, EllisonJM, SungYH, RenshawPF, HarperDG (2010) Neuropsychiatric correlates of white matter hyperintensities in Alzheimer’s disease. Int J Geriatr Psychiatry25, 780–788.
36.
HahnC, LimH-K, WonWY, AhnKJ, JungW-S, LeeCU (2013) Apathy and white matter integrity in Alzheimer’s disease: A whole brain analysis with tract-based spatial statistics. PloS One8, e53493.
37.
ChenYK, QuJF, XiaoWM, LiWY, LiW, FangXW, WengHY, LiuYL, LuoGP, UngvariGS, XiangYT (2015) Intracranial atherosclerosis and poststroke depression in Chinese patients with ischemic stroke. J Stroke Cerebrovasc Dis25, 998–1004.
38.
van SlotenTT, SigurdssonS, van BuchemMA, PhillipsCL, JonssonPV, DingJ, SchramMT, HarrisTB, GudnasonV, LaunerLJ (2015) Cerebral small vessel disease and association with higher incidence of depressive symptoms in a general elderly population: The AGES-Reykjavik Study. Am J Psychiatry172, 570–578.
39.
AkoudadS, de GrootM, KoudstaalPJ, van der LugtA, NiessenWJ, HofmanA, IkramMA, VernooijMW (2013) Cerebral microbleeds are related to loss of white matter structural integrity. Neurology81, 1930–1937.
HeringaSM, ReijmerYD, LeemansA, KoekHL, KappelleLJ, BiesselsGJ (2014) Multiple microbleeds are related to cerebral network disruptions in patients with early Alzheimer’s disease. J Alzheimers Dis38, 211–221.
42.
MegaMS, LeeL, DinovID, MishkinF, TogaAW, CummingsJL (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry69, 167–171.
43.
HommetC, MondonK, ConstansT, BeaufilsE, DesmidtT, CamusV, CottierJP (2011) Review of cerebral microangiopathy and Alzheimer’s disease: Relation between white matter hyperintensities and microbleeds. Dement Geriatr Cogn Disord32, 367.
44.
KirschW, McAuleyG, HolshouserB, PetersenF, AyazM, VintersHV, DicksonC, HaackeEM, BrittW3rd, LarsengJ, KimI, MuellerC, SchragM, KidoD (2009) Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis17, 599–609.
45.
MitchellAJ, Shiri-FeshkiM (2009) Rate of progression of mild cognitive impairment to dementia meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand119, 252–265.
46.
MiwaK, TanakaM, OkazakiS, YagitaY, SakaguchiM, MochizukiH, KitagawaK (2014) Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors. Neurology83, 646–653.
47.
GodinO, DufouilC, MaillardP, DelcroixN, MazoyerB, CrivelloF, AlpérovitchA, TzourioC (2008) White matter lesions as a predictor of depression in the elderly: The 3C-Dijon Study. Biol Psychiatry63, 663–669.
GyanwaliB, VroomanH, VenketasubramanianN, WongTY, ChengC-Y, ChenC, HilalS (2019) Cerebral small vessel disease and enlarged perivascular spaces-data from memory clinic and population-based settings. Front Neurol10, 669.
50.
HilalS, TanCS, AdamsHHH, HabesM, MokV, VenketasubramanianN, HoferE, IkramMK, AbrigoJ, VernooijMW, ChenC, HostenN, VolzkeH, GrabeHJ, SchmidtR, IkramMA (2018) Enlarged perivascular spaces and cognition: A meta-analysis of 5 population-based studies. Neurology91, e832–e842.
